• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.".

作者信息

Hochman Judith S, Maron David J

机构信息

Cardiovascular Clinical Research Center, Department of Medicine, NYU School of Medicine, New York, NY (J.S.H.). Stanford University School of Medicine, CA (D.J.M.).

出版信息

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004742. doi: 10.1161/CIRCOUTCOMES.118.004742.

DOI:10.1161/CIRCOUTCOMES.118.004742
PMID:29636347
Abstract
摘要

相似文献

1
Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.".霍奇曼和马伦就文章《非盲法试验中的“信念治愈”与“减法焦虑”：DEFER和FAME - 2对缺血性心脏病试验终点的启示》所写的信函。
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004742. doi: 10.1161/CIRCOUTCOMES.118.004742.
2
Correction to: Moving the Goalposts Into Unblinded Territory: The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA ['Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial].对以下内容的修正：将目标移至非盲法领域：DEFER和FAME 2的重大教训及其对ISCHEMIA试验中终点改变的影响[非盲法程序试验中的“信仰疗法”和“减法焦虑”：DEFER和FAME - 2对ISCHEMIA试验终点的启示]
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000038. doi: 10.1161/HCQ.0000000000000038.
3
'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial.未设盲试验中的“信念疗法”与“减法焦虑”：DEFER和FAME - 2试验为缺血性心脏病试验终点带来的经验教训
Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004665. doi: 10.1161/CIRCOUTCOMES.118.004665.
4
The Ultimate Goal Post.终极目标标杆。
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004744. doi: 10.1161/CIRCOUTCOMES.118.004744.
5
Faith-adapted psychological therapies for depression and anxiety: Systematic review and meta-analysis.信仰调整的心理疗法治疗抑郁和焦虑：系统综述和荟萃分析。
J Affect Disord. 2015 May 1;176:183-96. doi: 10.1016/j.jad.2015.01.019. Epub 2015 Jan 21.
6
Faith healing and faith in healing.信仰疗法与对康复的信念。
Indian J Med Ethics. 2015 Oct-Dec;12(4):238-40. doi: 10.20529/IJME.2015.063.
7
The perceived effectiveness of traditional and faith healing in the treatment of mental illness: a systematic review of qualitative studies.传统和信仰疗法治疗精神疾病的效果感知：定性研究的系统评价。
Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):555-566. doi: 10.1007/s00127-018-1519-9. Epub 2018 Apr 25.
8
Molar apicectomy with amalgam root-end filling: results of a prospective study in two district general hospitals.银汞合金根尖倒充填术：在两家区综合医院的前瞻性研究结果
Br Dent J. 2003 Dec 20;195(12):707-14; discussion 698. doi: 10.1038/sj.bdj.4810834.
9
Diagnosis and distress in Navajo healing.纳瓦霍族疗法中的诊断与痛苦
J Nerv Ment Dis. 2008 Aug;196(8):585-96. doi: 10.1097/NMD.0b013e3181812c68.
10
How faith heals: a theoretical model.信仰如何治愈：一个理论模型。
Explore (NY). 2009 Mar-Apr;5(2):77-96. doi: 10.1016/j.explore.2008.12.003.

引用本文的文献

1
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review.改善稳定性冠心病经皮冠状动脉介入治疗（PCI）临床试验设计：美国心脏病学会（JACC）最新观点综述。
J Am Coll Cardiol. 2020 Jul 28;76(4):435-450. doi: 10.1016/j.jacc.2020.05.060.
2
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.基于个体患者数据的荟萃分析：冠状动脉狭窄稳定患者采用血流储备分数指导的经皮冠状动脉介入治疗与药物治疗的比较。
Eur Heart J. 2019 Jan 7;40(2):180-186. doi: 10.1093/eurheartj/ehy812.
3
ISCHEMIA: Establishing the Primary End Point.
缺血：确立主要终点
Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004791. doi: 10.1161/CIRCOUTCOMES.118.004791.